FTWA
WST icon

Fifth Third Wealth Advisors’s West Pharmaceutical WST Stock Holding History

Fifth Third Wealth Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$457K Buy
1,272
+351
+38% +$107K 0.01% 527
2026
Q1 		$231K Buy
+921
New +$229K 0.01% 720
2025
Q1 		– Sell
-631
Closed -$207K – 756
2024
Q4 		$207K Buy
+631
New +$199K 0.01% 688
2024
Q3 		– Sell
-670
Closed -$221K – 733
2024
Q2 		$221K Buy
+670
New +$237K 0.02% 556

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Fifth Third Wealth Advisors's WST Position: Q2 2026 in Review

Fifth Third Wealth Advisors increased its West Pharmaceutical (WST) stake by 38% in Q2 2026, buying an estimated $107K and bringing the position to 1,272 shares worth $457K. The position accounts for 0.01% of the portfolio, ranked #527.

Fifth Third Wealth Advisors first reported a position in WST in Q2 2024 and has held it in 4 quarters since. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Fifth Third Wealth Advisors held 1,272 shares of West Pharmaceutical worth $457K as of Q2 2026.
  • Fifth Third Wealth Advisors bought 351 West Pharmaceutical shares in Q2 2026, an estimated $107K.
  • West Pharmaceutical made up 0.01% of Fifth Third Wealth Advisors's portfolio in Q2 2026, its #527 holding.
  • Fifth Third Wealth Advisors first reported a position in West Pharmaceutical in Q2 2024 and has held it in 4 quarters since.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Fifth Third Wealth Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.